Stay updated on First-in-Human Study of EYP-1901 in wAMD Clinical Trial
Sign up to get notified when there's something new on the First-in-Human Study of EYP-1901 in wAMD Clinical Trial page.

Latest updates to the First-in-Human Study of EYP-1901 in wAMD Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedFooter shows Revision: v3.3.4 replacing v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedA new Locations section has been added, listing participating sites by state (Arizona, California, Florida, Massachusetts, North Carolina, Pennsylvania, Texas). The page version has been updated to v3.3.3 and the HHS Vulnerability Disclosure link has been removed.SummaryDifference0.9%

- Check52 days agoChange DetectedThe page shows an updated revision line: Revision: v3.3.2, replacing the previous v3.3.1. This appears to be a technical revision with no changes to study data or page content.SummaryDifference0.1%

- Check59 days agoChange DetectedPublications section updated to indicate entries are auto-filled from PubMed and a revision tag (v3.3.1) was added.SummaryDifference0.1%

- Check67 days agoChange DetectedRemoved the government funding lapse notice from the page.SummaryDifference0.4%

- Check81 days agoChange DetectedNo significant changes to core content such as study details, eligibility criteria, locations, or outcomes; the changes appear to be minor visual or layout adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to First-in-Human Study of EYP-1901 in wAMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the First-in-Human Study of EYP-1901 in wAMD Clinical Trial page.